Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
about
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesProgressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques.Mapping pathological changes in brain structure by combining T1- and T2-weighted MR imaging data.MRI in multiple sclerosis: what's inside the toolbox?MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain.Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesionsDifferentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.Neuroradiological evaluation of demyelinating diseaseThe Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.Gender issues in multiple sclerosis: an update.Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.Evaluating response to disease-modifying therapy in relapsing multiple sclerosis.Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.MRI characteristics of familial and sporadic multiple sclerosis patients.Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: a preliminary study.Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria.Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials.Intensity ratio to improve black hole assessment in multiple sclerosis.Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability.Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.Gender-related differences in MS: a study of conventional and nonconventional MRI measures.Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patientsLarge-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
P2860
Q28299872-8B575913-1B65-4D3F-B3F1-8DEFEE6CB5D8Q30928115-2B86F722-E0DB-470A-946F-410A88500515Q30940046-FCE1648E-535B-4F46-AB85-8C1E42414C2FQ30976200-45188EF2-E5E9-4A70-ABC3-EC03048927BBQ31132442-F278B60E-C8C7-4B02-ABBD-CE41831B6A63Q33211281-6C228BAF-D5FE-49CC-AC5F-0C6E8CEE4CF3Q33791632-D991FD9B-2AF9-48B7-AA06-F61A66ADD279Q35198492-186DCBF2-E1A6-4D54-957B-83A44D083D80Q35529707-C11F9F3F-4E52-48AE-A98E-06850C985321Q36999734-33AA4D93-A47B-4FBB-9DCB-D18CE2222679Q37048758-4C0CA9F7-2E1E-487E-B733-B7834C957CC2Q37813691-4A4E8112-790F-4901-8AEC-64F641A02FDBQ38265170-6E67786C-4CE1-45A0-8056-5B7788E24814Q38375605-F2C47EFC-D4EB-47F6-AF0C-A004B173E50AQ39606176-CC9764D3-0ADA-48C1-AEF3-3EF08D6E118EQ39800991-89A1D8A0-F8A1-421E-BE8C-077E710076B7Q41687816-5C7E2FD7-14B3-4116-8E0B-EB6E7AD6BBFAQ43432395-6360FE64-CC83-498C-A900-38D92A4F8130Q43957760-E0561ADC-B247-4B36-9BC4-0CD50C8CCF4FQ44887683-7B88E655-F4CA-48EA-B0C0-6C3F7C37D196Q44981816-A283FE61-5F9D-4543-8D1E-69241C733205Q46866052-739AAB71-72D8-4583-A354-04EBA27EC6B1Q47131179-E12C5FEA-ABAD-4698-9860-CBD1E624D4F3Q47924405-E47D2E0F-022A-4402-B763-F3497F520655Q48031815-AC11E2A3-B799-4865-A619-8E9E548C2BA7Q48134359-CCF72C77-5BEB-40FD-817F-3421C7D62E2BQ48422020-FC2D0AE7-5AC7-499A-85FF-AC863B2AB40AQ48565199-8BC21513-ABB5-4A8F-810A-0464C4CC9CA2Q48572300-3436C854-3DD0-4B9F-892C-ACF9CD635E0DQ51026340-2F55BB24-38E3-4652-A490-BFF92A321C1AQ51672793-64F6A99C-1734-4623-81CB-63200AB48048Q52849668-1CA3F94E-69AD-4E98-90D8-335BF7B9B5ADQ57221960-0E6B36B9-6700-4B2B-B189-DDC159477FEAQ57911818-56ED2542-306D-4315-ABF4-17A8EE1E5EFA
P2860
Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@en
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@nl
type
label
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@en
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@nl
prefLabel
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@en
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@nl
P2093
P356
P1433
P1476
Hypointense lesions on T1-weig ...... ients with multiple sclerosis.
@en
P2093
Castelijns JA
Lycklama A Nijeholt GJ
van Walderveen MA
P356
10.1001/ARCHNEUR.58.1.76
P577
2001-01-01T00:00:00Z